IVIM & OLINK in Sarcoma

计划入组 145 人 · 首次发布于 2023 年 7 月 18 日

Plasma Proteomics Study of End-Stage Liver Disease Patients Based on Olink Technology

计划入组 58 人 · 首次发布于 2025 年 3 月 10 日

Randomized, Double Blind Trial of Bromfenac BID (0.09%) as an Adjunct to Argon Laser Therapy in the Treatment of Diabetic Macular Edema.

计划入组 50 人 · 首次发布于 2008 年 9 月 25 日

LH-05 (Link Heealth Group)

Link-TSG6 treament for Osteoarthritis (OA)

Abalone haemocyanin (Marine Biotechnology Australia/Bio-Link)

Olink Holding AB

Sweden

BeCare Link, LLC

United States

Link Medicine Corporation

United States

Verici Dx Achieves Olink Certified Service Provider Status, Expanding Proteomics Capabilities for Transplant Diagnostics

Children's Hospital launches Canada's first paediatric Olink lab, advancing precision medicine for children

Proteomics-Driven Multiomic Studies Reveal Novel Drug Targets and Repurposing Opportunities Across Cardiovascular, Psychiatric, and Autoimmune Diseases